The AAN response to evidence-based medicine: Promise and pitfalls

Multiple Sclerosis Journal

Volumn 18, Issue 7, 2012, Pages 949-950

  Gronseth, Gary S ^a   Ashman, Eric ^b  

^a AMERICAN ACADEMY OF NEUROLOGY   (United States)

^b 673rd Medical Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; VITAMIN D;

CLINICAL EFFECTIVENESS; DISEASE EXACERBATION; EVIDENCE BASED MEDICINE; FOLLOW UP; HUMAN; MORTALITY; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; SHORT SURVEY;

EID: 84863191947     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458512448449     Document Type: Short Survey

References (12)

1. Gross RA, Johnston KC. Levels of Evidence: Taking Neurology to the next level. Neurology 2009; 72: 8-10.
2. Goodin DS, Reder AT. Evidence-based medicine: promise and pitfalls. Mult Scler 2102; [in press].
3. French J, Gronseth G. Lost in a jungle of evidence: We need a compass. Neurology 2008; 71: 1634-1638.
4. Stein MS, Liu Y, Gray OM, Baker JE, Kolbe SC, Ditchfield MR, et al. A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis. Neurology 2011; 77: 1611-1618.
5. Goodin DS, Reder AT, Ebers GC, Cutter G, Kremenchutzky M, Oger J, et al. Survival in MS A randomized cohort study 21 years after the start of the pivotal INNβ-1b trial. Neurology 2012; 78: 1315-1322.
6. AAN (American Academy of Neurology). Clinical Practice Guideline Process Manual, 2011 Ed. St. Paul, MN: The American Academy of Neurology; 2011.
7. Schultz KF, Altman DG, Moher D. CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials. Ann Intern Med 2010; 152; 1-8.
8. Hitt E. Interferon Beta-1b Prolongs Survival in MS Patients. Medscape Medical News 2011. www.medscape.com/view-article/743759-print. [Accessed April 16, 2012.]
9. Goodin DS, Reder AT. IFNB Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 1993; 43: 655-661.
10. Moye LA. P-Value Interpretation and Alpha Allocation in Clinical Trials. Annals of Epidemiology 1998; 8: 351-357. (Pubitemid 28340535)
11. McGauran N, Wieseler B, Kreis J, Schüler YB, Kölsch H, Kaiser T. Reporting bias in medical research - a narrative review. Trials 2010; 11; 1-15.
12. Abdi, H. Bonferroni and Šidák corrections for multiple comparisons. In: Salkind NJ, editor. Encyclopedia of Measurement and Statistics. Thousand Oaks, CA: Sage. 2007. http://www.utdallas.edu/~herve/Abdi- Bonferroni2007-pretty.pdf. [Accessed April 16, 2012.]